GlaxoSmithKline Prize

GlaxoSmithKline Prize is an esteemed award given annually by the Royal Society, the United Kingdom's national academy of sciences. The prize is sponsored by the multinational pharmaceutical company GlaxoSmithKline (GSK), and it recognizes outstanding contributions to medical and veterinary sciences.

History

The GlaxoSmithKline Prize was established in 1980 by the Wellcome Trust, a biomedical research charity based in London. The Trust was founded by Sir Henry Wellcome, a pharmaceutical entrepreneur, and it was initially funded by the profits of the pharmaceutical company Burroughs Wellcome, which later became part of GlaxoSmithKline.

Eligibility and Criteria

The GlaxoSmithKline Prize is open to scientists of all nationalities. The award is given for original contributions to medical and veterinary sciences published within ten years from the date of the award. The work should be of international significance, and the candidate should have made a substantial personal contribution to the discovery.

Award

The recipient of the GlaxoSmithKline Prize receives a medal, a personal prize of £2,500, and a grant of £15,000 for their research. The winner is also invited to deliver a lecture at the Royal Society.

Notable Recipients

Over the years, the GlaxoSmithKline Prize has been awarded to many distinguished scientists. Some notable recipients include Elizabeth Blackburn, for her work on telomeres, and Shinya Yamanaka, for his research on induced pluripotent stem cells.

See Also

• List of science and technology awards
• Royal Society Prizes for Science